Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B. Mateos-Munoz B, Buti M, Vazquez IF, Conde MH, et al. Dig Dis Sci 2023 Feb 3. doi: 10.1007/s10620-022-07817.

Read + Share

Amedeo Smart

Independent Medical Education

Mateos-Munoz B, Buti M, Vazquez IF, Conde MH, et al. Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B. Dig Dis Sci 2023 Feb 3. doi: 10.1007/s10620-022-07817.
PMID: 36737575